<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00377039</url>
  </required_header>
  <id_info>
    <org_study_id>AD337-021</org_study_id>
    <nct_id>NCT00377039</nct_id>
  </id_info>
  <brief_title>A Multicentre Trial to Determine the Efficacy and Safety of AD-337 in the Treatment of Fibromyalgia</brief_title>
  <official_title>A Multi-Centre, Randomised, Double-Blind, Placebo Controlled, Parallel Group Exploratory Study to Investigate the Efficacy, Safety and Tolerability of AD 337 in the Treatment of Fibromyalgia in Female Subjects.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sosei</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Sosei</source>
  <brief_summary>
    <textblock>
      This is a multicentre, randomized, double-blind, placebo controlled, parallel group
      exploratory study to investigate the efficacy, safety and tolerability of AD 337 in the
      treatment of fibromyalgia in female subjects.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>August 2006</start_date>
  <completion_date type="Actual">August 2007</completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The Fibromyalgia Impact Questionnaire total score after 4 weeks treatment</measure>
  </primary_outcome>
  <secondary_outcome>
    <measure>These will be</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>FIQ Total score at weeks 1, 2, 3, at end of study and overall</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>FIQ subscales at weeks 1, 2, 3, 4 at end of study and overall</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Short form McGill Pain questionnaire subscales at weeks 1, 2, 3, 4 at end of study and overall</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Tender point assessment (ACR 1990 criteria) scores at weeks 2, 4 at end of study and overall</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hospital Anxiety and Depression Scale subscales at weeks 2, 4 and overall</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Fibromyalgia Health Assessment Questionnaire total score at weeks 1, 2, 3, 4 at end of study and overall</measure>
  </secondary_outcome>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Fibromyalgia</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>AD 337</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Female

          -  Age 18-65

          -  Meet ACR 1990 criteria for classification of Fibromyalgia

          -  Able and willing to discontinue CNS active therapies

        Exclusion Criteria:

          -  If pain is NOT primarily due to Fibromyalgia

          -  Current or prior history of serious psychiatric disorder

          -  Pregnant/breastfeeding

          -  QTc &gt; 470ms

          -  Failure to respond to 2 or more adequate regimes of different classes of
             antidepressants.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>David L Scott</last_name>
    <role>Principal Investigator</role>
    <affiliation>King's College London</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>David L Scott</name>
      <address>
        <city>London</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>September 2007</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 14, 2006</study_first_submitted>
  <study_first_submitted_qc>September 14, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 15, 2006</study_first_posted>
  <last_update_submitted>September 30, 2007</last_update_submitted>
  <last_update_submitted_qc>September 30, 2007</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 2, 2007</last_update_posted>
  <keyword>ACR 1990 Fibromyalgia</keyword>
  <keyword>Fibromyalgia Impact Questionnaire</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fibromyalgia</mesh_term>
    <mesh_term>Myofascial Pain Syndromes</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

